Nishiyama Y - Search Results

1

Replication-competent, oncolytic herpes simplex virus type 1 mutants induce a bystander effect following ganciclovir treatment.

Luo C, Mori I, Goshima F, Ushijima Y, Nawa A, Kimura H, Nishiyama Y. Luo C, et al. Among authors: nishiyama y. J Gene Med. 2007 Oct;9(10):875-83. doi: 10.1002/jgm.1085. J Gene Med. 2007. PMID: 17685493

2

Oncolytic viral therapy for human ovarian cancer using a novel replication-competent herpes simplex virus type I mutant in a mouse model.

Nawa A, Nozawa N, Goshima F, Nagasaka T, Kikkawa F, Niwa Y, Nakanishi T, Kuzuya K, Nishiyama Y. Nawa A, et al. Among authors: nishiyama y. Gynecol Oncol. 2003 Oct;91(1):81-8. doi: 10.1016/s0090-8258(03)00417-7. Gynecol Oncol. 2003. PMID: 14529666

3

Oncolytic viral therapy for breast cancer with herpes simplex virus type 1 mutant HF 10.

Teshigahara O, Goshima F, Takao K, Kohno S, Kimata H, Nakao A, Nishiyama Y. Teshigahara O, et al. Among authors: nishiyama y. J Surg Oncol. 2004 Jan;85(1):42-7. doi: 10.1002/jso.20005. J Surg Oncol. 2004. PMID: 14696086

4

Herpes simplex virus type 1 mutant HF10 oncolytic viral therapy for bladder cancer.

Kohno S, Luo C, Goshima F, Nishiyama Y, Sata T, Ono Y. Kohno S, et al. Among authors: nishiyama y. Urology. 2005 Nov;66(5):1116-21. doi: 10.1016/j.urology.2005.05.041. Urology. 2005. PMID: 16286150

5

Association of two membrane proteins encoded by herpes simplex virus type 2, UL11 and UL56.

Koshizuka T, Kawaguchi Y, Goshima F, Mori I, Nishiyama Y. Koshizuka T, et al. Among authors: nishiyama y. Virus Genes. 2006 Apr;32(2):153-63. doi: 10.1007/s11262-005-6871-7. Virus Genes. 2006. PMID: 16604447

6

Intercellular trafficking and cytotoxicity of recombinant HSV-1 thymidine kinase fused with HSV-2 US11 RXP repeat peptide.

Luo C, Nawa A, Yamauchi Y, Kohno S, Ushijima Y, Goshima F, Kikkawa F, Nishiyama Y. Luo C, et al. Among authors: nishiyama y. Virus Genes. 2007 Jun;34(3):263-72. doi: 10.1007/s11262-006-0013-8. Epub 2006 Aug 22. Virus Genes. 2007. PMID: 16927131

7

Determination and analysis of the DNA sequence of highly attenuated herpes simplex virus type 1 mutant HF10, a potential oncolytic virus.

Ushijima Y, Luo C, Goshima F, Yamauchi Y, Kimura H, Nishiyama Y. Ushijima Y, et al. Among authors: nishiyama y. Microbes Infect. 2007 Feb;9(2):142-9. doi: 10.1016/j.micinf.2006.10.019. Epub 2006 Dec 12. Microbes Infect. 2007. PMID: 17218138 Free article.

8

[Oncolytic virotherapy using replication-competent herpes simplex viruses].

Nishiyama Y, Goshima F. Nishiyama Y, et al. Uirusu. 2007 Jun;57(1):57-65. doi: 10.2222/jsv.57.57. Uirusu. 2007. PMID: 18040155 Free article. Review. Japanese.

9

Microarray analysis of transcriptional responses to infection by herpes simplex virus types 1 and 2 and their US3-deficient mutants.

Kamakura M, Nawa A, Ushijima Y, Goshima F, Kawaguchi Y, Kikkawa F, Nishiyama Y. Kamakura M, et al. Among authors: nishiyama y. Microbes Infect. 2008 Apr;10(4):405-13. doi: 10.1016/j.micinf.2007.12.019. Epub 2008 Jan 9. Microbes Infect. 2008. PMID: 18403238 Free article.

10

Non-engineered, naturally oncolytic herpes simplex virus HSV1 HF-10: applications for cancer gene therapy.

Nawa A, Luo C, Zhang L, Ushjima Y, Ishida D, Kamakura M, Fujimoto Y, Goshima F, Kikkawa F, Nishiyama Y. Nawa A, et al. Among authors: nishiyama y. Curr Gene Ther. 2008 Jun;8(3):208-21. doi: 10.2174/156652308784746422. Curr Gene Ther. 2008. PMID: 18537595 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,809 results

Search Page

Filters